z-logo
Premium
Prevention by the 5‐HT 3 receptor antagonist, ondansetron, of morphine‐dependence and tolerance in the rat
Author(s) -
Hui SiuChun G.,
Sevilla Elenita L.,
Ogle Clive W.
Publication year - 1996
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1111/j.1476-5381.1996.tb15504.x
Subject(s) - morphine , ondansetron , physical dependence , antagonist , (+) naloxone , receptor antagonist , opiate , pharmacology , conditioned place preference , 5 ht receptor , chemistry , anesthesia , serotonin , medicine , receptor , vomiting
1 The effect of ondansetron, a selective 5‐hydroxytryptamine 3 (5‐HT 3 ) receptor antagonist, was studied in morphine‐addicted rats. Morphine‐dependence and tolerance, induced by drinking increasing concentrations of morphine sulphate in 5% sucrose solution for 3 weeks, were demonstrated by the naloxone‐precipitated withdrawal syndrome and tail flick response to a thermal noxious stimulus (water at 50°C), respectively. 2 Morphine‐dependence, assessed by naloxone precipitated withdrawal, was undetectable by the 6th day, when the animals drank only tap water for 7 days after the 3‐week induction period. 3 When detoxified rats were offered sucrose and morphine solutions for 10 days, the recurrence of opiate solution preference with relapse to dependence and tolerance was observed. 4 Giving ondansetron (0.1 or 1 μg kg −1 ; i.p.; twice daily) on the 14th day of, or 7 days prior to, the 3‐week induction period reduced dependence and tolerance seen during the 3‐week morphine induction and the 10‐day drinking preference periods. 5 5‐Hydroxytryptamine 2 (5‐HT 2 ) receptor antagonism by cyproheptadine (100 or 250 μg kg −1 ; i.p.; twice daily) did not influence morphine‐dependence and tolerance. 6 These findings suggest that ondansetron may be useful for treating opiate addiction and lowering the recidivism rate.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here